Related Experiment Videos
Studies on the genotoxic effects of aminophenazines using two cellular models and three different methods
A Cebulska-Wasilewska1, D Nowak, W Niedzwiedz
1Institute of Nuclear Physics, Department of Radiation and Environmental Biology, Krakow, Poland. wasilews@alf.ifj.edu.pl
Mutation Research
|December 29, 1999
Summary
This study investigated the genotoxicity of 2,3-diaminophenazine (DAP) and 2-amino-3-hydroxyphenazine (AHP) in human cells. Both compounds induced DNA and chromosomal damage, with DAP showing higher genotoxicity.
Area of Science:
- Toxicology
- Molecular Biology
- Genetics
Background:
- Aminophenazines are a class of compounds with potential biological activity.
- Understanding the genotoxicity of specific aminophenazines is crucial for risk assessment.
Purpose of the Study:
- To evaluate the genotoxic potential of 2,3-diaminophenazine (DAP) and 2-amino-3-hydroxyphenazine (AHP) in human lymphocytes.
- To compare the genotoxic effects of DAP and AHP at both DNA and chromosomal levels.
Main Methods:
- Alkaline single cell gel electrophoresis (SCGE) assay for DNA strand breaks.
- Cytogenetic assays including chromosome aberrations (CA) and sister chromatid exchange (SCE) analysis.
- In vitro testing using human lymphocytes.
Main Results:
- Both DAP and AHP demonstrated genotoxic activity, increasing DNA and chromosomal damage.
- A positive correlation was observed between DNA damage and chromosomal aberrations.
- 2,3-diaminophenazine (DAP) exhibited greater genotoxicity compared to 2-amino-3-hydroxyphenazine (AHP).
Conclusions:
- Aminophenazines DAP and AHP are genotoxic to human lymphocytes.
- The observed genotoxicity is concentration-dependent.
- DAP is a more potent genotoxic agent than AHP in human cells, consistent with bacterial system findings.